A B S T R A C T Studies were performed to ascertain the effect of urushiol analogues on the in vitro lymphocyte blastogenesis elicited by urushiol in peripheral blood lymphocytes taken from individuals sensitized to poison oak or ivy. Urushiol is a mixture of alkylcatechols composed of a catechol ring coupled to mono-, di-, or tri-unsaturated C-15 or C-17 carbon side chains. Each of these two moieties, catechol ring and side chain, was tested for its role in eliciting reactivity. Analogues tested represented the catechol ring (3-methylcatechol), the mono-or di-unsaturated side chain (oleic or linoleic acid), and the saturated side chain coupled to a catechol ring (pentadecylcatechol), a blocked catechol ring (heptadecylveratrole), or a resorcinol (pentadecylresorcinol). Urushiol with a blocked catechol ring (urushiol dimethyl ether) was also included.
INTRODUCTION
In a previous report (1) we demonstrated that urushiol-specific blastogenesis can be elicited from cultured peripheral blood lymphocytes taken from individuals spontaneously or experimentally sensitized against poison oak. The reactive cell is a T lymphocyte which requires an accessory cell from the Tdepleted population (probably a macrophage) to produce blastogenesis. The response has a narrow dose range, and supraoptimal doses of urushiol produce a sharp inhibition of response. Urushiol can be introduced into cultures on heterologous, homologous, or autologous erythrocyte membranes or on autologous lymphocytes with equal efficiency. Although the alkylcatechols that compose urushiol concentrate into membranes and remain firmly associated through aqueous washes, the association does not appear to be irreversible because the majority of the radioactivity introduced with a radiolabeled hapten can be removed with organic solvents (1) .
Studies on T-cell mediated immunity to haptens have suggested that covalent linkage between the hapten and a carrier inacromolecule (protein) is required to evoke a blastogenesis response in vitro (2) . The carrier protein is thought to associate with a macrophage-like cell which may either present the surface-bound hapten as such or, alternatively, may process the hapten internally before presentation to a reactive T cell (3) . Urushiol is a mixture of catechols that are readily oxidized to electrophilic o-quinones thought to be capable of spontaneously alkylating nucleophilic functionalities present in cell membrane proteins. It has been suggested that this mechanism of binding is responsible for the potent in vivo sensitizing properties of urushiol (4) . However, our in vitro studies indicated that the great majority of the urushiol that produced blastogenesis was reversibly bound to the cell membranes used to introduce it into culture (1) . This suggests that the catechol ring is not as capable of spontaneous auto-oxidation and covalent bond formation as originally suggested. To determine if there was a requirement for the catechol ring for reactivity and to evaluate the influence of the catechol ring and unsaturated side chains on biological reactivity, the ability of urushiol analogues to evoke blastogenesis or to block urushiol-induced blastogenesis has been studied. added to cultures on erythrocyte membranes such that one batch of membranes carried both urushiol and the analogue. Because 3-methylcatechol is water soluble it was added directly to cultures. Analogue-urushiol membranes were prepared by resuspending 1010 human erythrocytes (RBC) in 4.5 ml of Hanks' balanced salt solution (HBSS). To this was added 0.5 ml of dimethyl sulfoxide (DMSO) that contained 0.5 mg ofanalogue, and, after incubation for 30 min at room temperature, 40 ml of sterile water was added and the mixture was centrifuged at 20,000 g for 30 min, and the membranes were resuspended in water. After two additional water washes, the membranes were suspended in 4.5 ml of water to which 0.5 mg of urushiol in 0.5 ml of DMSO had been added. After a second 30-min incubation at room temperature, the membranes were washed as before and resuspended in HBSS at the appropriate concentration and added to cultures.
METHODS
Three series of studies were carried out with radiolabeled compounds to quantitate the amount of membrane-bound analogue and urushiol, which were thus introduced to the cultures. In the first series, [3H]HDC or [3H]HDV was mixed with the unlabeled compound and then added in 0.5 ml of DMSO to 4.5 ml of HBSS that contained 1010 RBC. After a 30-min incubation period at room temperature and three water washes as before, the membranes were resuspended in 2.0 ml of water, and an aliquot was dissolved in NCS solubilizer (Amersham Corp., Arlington Heights, Ill.) and counted as previously described (1) . In the second series of experiments, radiolabeled HDC or HDV was added at different concentrations in 0.5 ml of DMSO to HBSS that contained 1010 RBC. After incubation and three water washes, the membranes were resuspended again in 4.5 ml of HBSS and unlabeled HDC, HDV, or urushiol was added at various concentrations in 0.5 ml of DMSO. After incubation and water washes the membranes were again resuspended and an aliquot was digested and counted as before. In the third series, the sequence was reversed; the unlabeled material was added, and then after three washes the labeled material was added. It was assumed for purposes of calculation that all of the analogue and/or urushiol added to the RBC membranes was taken up into the membranes. In one set of experiments, radiolabeled PDC was used instead of radiolabeled HDC because of scarcity of materials.
Blastogenesis assay. Lymphocyte blastogenesis was assayed by the methods previously described (1) . Peripheral blood lymphocytes from a reactive donor were separated and cultured in microwells in RPMI 1640 with 10% autologous serum added. In most cases, the analogues and/or urushiol on RBC membranes were added at various concentrations to the wells. The 3-methylcatechol was added directly to the cultures either at fixed concentrations or at concentrations such that the molarity of 3-methylcatechol in each culture represented the same as that of the urushiol added on RBC membranes. Concanavalin A-induced blastogenesis was carried out as previously described (1).
Statistical analysis. Data from multiple experiments were compared in Table III Table I . Therefore, cultures either contained urushiol on RBC membranes, analogues on RBC membranes, or equimolar concentrations of urushiol plus analogue. The effects of the analogue on urushiol-mediated blastogenesis are shown in Fig. 2A . Both HDV and PDR produced marked amplification of the response. This amplification effect was extended through all the dose ranges.
There was no inhibitory effect. The effect of 3-methylcatechol on the urushiol response was also tested. Because 3-methylcatechol is water soluble, it would not be expected to bind to RBC membranes. Therefore, urushiol was added to cultures on RBC membranes as before, and 3-methylcatechol was added to each culture at a concentration equimolar to that of the urushiol. As can be seen in Fig. 2B , this compound inhibited the urushiol response over a wide dose range.
This inhibition was further investigated in a second set ofexperiments shown in Fig. 3 . Four sets ofcultures were prepared, each containing increasing doses of RBC-bound urushiol. To each of the sets was added either 1,667 pmol of 3-methylcatechol, 833 pmol of 3-methylcatechol, 417 pmol of 3-methylcatechol, or no analogue. Controls included concanavalin A added to each set of cultures. All three concentrations of3-methylcatechol produced inhibition ofthe urushiol response in a dose-dependent fashion. This inhibition was antigen specific because the concanavalin A response was not affected by either urushiol or 3-methylcatechol.
The effect of PDC on urushiol-induced blastogenesis was complex because the apparent effect of PDC was to inhibit the urushiol reactivity produced by optimal urushiol concentrations (Figs. 4 and 5) . Dose-response analysis, however, established that the entire urushiol response curve had been shifted to the left, such that high levels of blastogenesis were being produced at levels of urushiol which normally were completely inactive. For example (Fig. 4) (6) . The di-unsaturated side chain must be coupled to a catechol to produce a blastogenic reaction in vitro. Compounds mimicking the di-unsaturated side chain (linoleic acid) or the mono-unsaturated side chain (oleic acid) of urushiol were inactive in vitro. Also inactive was 3-methylcatechol, as was an equimolar mixture of 3-methylcatechol and linoleic acid. The catechol moiety is essential for reactivity because neither PDR nor HDV was active. These compounds share the saturated side chain with HDC and PDC, but have ring structures unable to generate reactive electrophilic species. The necessity for a catechol ring is further supported by the finding that UDE, incapable of forming the electrophilic o-quinone, is also inactive, even though this species retains the unsaturated sidechain moiety. Four of the urushiol analogues, PDC, PDR, HDV, and 3-methylcatechol, were tested for their effect on urushiol-induced blastogenesis. Three of these analogues, PDC, PDR, and HDV, share long C-15-or C-17-saturated side chains coupled to ring structures. HDV and PDR, however, do not have the reactive catechol function. These two compounds amplified the response to urushiol. The dose range of this amplified response was the same as that of urushiol alone. The two compounds with active catechol rings, PDC and 3-methylcatechol, both produced inhibition of the urushiol response. This inhibition was studied further with 3-methylcatechol. It was shown that as the concentration of this analogue was increased, the inhibitory effect on the urushiol response became more profound. The inhibition appeared antigen specific because blastogenesis induced with the mitogen concanavalin A was not affected by inhibitory concentrations of 3-methylcatechol. This series of experiments suggests that the catechol ring of urushiol interacts with a specific receptor. This receptor may be antigen specific, recognizing the catechol ring as its epitope, or relatively less specific in which it simply allows a covalent bond to form joining the urushiol hapten to a carrier.
Our experiments also suggest that the RBC carriers used in these experiments to introduce urushiol into the culture preparations may not be the ultimate carrier for the hapten urushiol. That is, the urushiol may be passed to some accessory cell which may oxidize it to the quinone and lead to covalent macromolecular adducts. This antigen may then be presented to sensitized T cells. These experiments do indicate that urushiol is initially presented to the immune machinery as the catechol because, otherwise, 3-methyleatechol should not block the reaction.
One of the analogues, PDC, produced a small blastogenic response when used alone to stimulate cultures. When added with urushiol it produced a leftward shift in the urushiol blastogenic response curve. The dose of urushiol required for optimal blastogenic response was reduced 50-fold. The noncatechol analogues did not produce this shift nor did 3-methylcatechol. The effect was not simply additive because the response elicited by urushiol or PDC alone at these concentrations was significantly lower. Regardless of the ratio, the optimal response of the PDC/urushiol mixture occurred at about the same total alkylcatechol concentration as that required for optimal reactivity to PDC or urushiol alone. The PDC shift was observed consistently when the PDC and urushiol were on the same carrier RBC membrane. This effect may be explained in several ways. PDC simply may be incorporated into the membrane of the presenter cell and thereby stabilize the specific antigen being presented to the blastogenically reactive T cell. In this case, PDC would be expected to be a nonspecific enhancer of antigen presentation and T-cell blastogenesis. An alternative possibility is that the requirement for the catechol ring is -50 times greater than the requirement for the di-unsaturated side chain, and this need can be met by either PDC or urushiol. Because of its low lipid solubility, 3- methylcatechol would not meet this requirement.
The role of the unsaturated side chain in the hapten remains unclear. There is a marked loss of reactivity both in vivo (6) and in vitro if individuals immunized against the native oil that contains the unsaturated side chains are tested with the saturated side-chain compound, PDC. This suggests that a T-cell receptor may be directed against the side chain. However because of their lipophilic nature, the alkylcatechols should orient themselves in a membrane with the catechol ring near the surface and the hydrophobic chain buried deep in the membrane. It is thus difficult to conceive how the side chain could move out of the lipid membrane across aqueous media and trigger a specific response. One mechanism may be a membrane vessicle (7) . Alternatively, specificity of the blastogenically active T cell may be against the catechol ring, and the increased reactivity with the unsaturated side-chain compounds could be a result of an altered presentation of the ring.
